AMISULPRIDE

AMISULPRIDE was reported 6122 times

AMISULPRIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CSF MEASLES ANTIBODY POSITIVE 11 0.8462
1 DELAYED VISUAL MATURATION 5 0.3125
2 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 190 0.2750
3 SEXUAL LIFE IMPAIRMENT 13 0.2653
4 RUBELLA ANTIBODY POSITIVE 11 0.1930
5 REFUSAL OF EXAMINATION 25 0.1908
6 EXCESSIVE SEXUAL FANTASIES 11 0.1833
7 ASTEATOSIS 15 0.1271
8 HUMAN BITE 10 0.1205
9 TOBACCO INTERACTION 12 0.1081
10 DISINHIBITION 172 0.1068
11 ENDOCARDITIS ENTEROCOCCAL 15 0.1056
12 NEGATIVE SYMPTOMS IN SCHIZOPHRENIA 7 0.1045
13 ANTIPSYCHOTIC DRUG LEVEL DECREASED 53 0.0998
14 DIFFUSE LARGE B-CELL LYMPHOMA STAGE II 6 0.0938
15 ANTICHOLINERGIC EFFECT 7 0.0933
16 BLADDER TRABECULATION 6 0.0741
17 BLOOD BRAIN BARRIER DEFECT 11 0.0724
18 DELUSION OF REFERENCE 10 0.0719
19 SOMATIC SYMPTOM DISORDER OF PREGNANCY 5 0.0714
20 REBOUND PSYCHOSIS 15 0.0704
21 NEGLECT OF PERSONAL APPEARANCE 16 0.0658
22 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 56 0.0629
23 SPASMODIC DYSPHONIA 19 0.0627
24 WAXY FLEXIBILITY 11 0.0625
25 CHORIORETINAL SCAR 5 0.0602
26 ORGANIC BRAIN SYNDROME 11 0.0585
27 SUBACUTE ENDOCARDITIS 6 0.0583
28 SARCOMA METASTATIC 7 0.0504
29 ANTIPSYCHOTIC DRUG LEVEL INCREASED 139 0.0493
30 CYTOTOXIC CARDIOMYOPATHY 4 0.0488
31 POSTMORTEM BLOOD DRUG LEVEL INCREASED 18 0.0483
32 PANCREAS INFECTION 19 0.0473
33 MONOCYTOSIS 29 0.0467
34 SENSORY OVERLOAD 9 0.0457
35 DRUG-GENETIC INTERACTION 15 0.0420
36 THUNDERCLAP HEADACHE 11 0.0420
37 MITRAL VALVE REPLACEMENT 16 0.0404
38 SCHIZOAFFECTIVE DISORDER 72 0.0403
39 ELECTROCARDIOGRAM QT SHORTENED 12 0.0396
40 ANTISOCIAL PERSONALITY DISORDER 5 0.0388
41 RED BLOOD CELL SEDIMENTATION RATE DECREASED 10 0.0383
42 THERAPEUTIC PRODUCT EFFECT VARIABLE 148 0.0381
43 TERM BIRTH 5 0.0362
44 ONYCHOPHAGIA 10 0.0362
45 EOSINOPHIL COUNT DECREASED 85 0.0357
46 POLYDIPSIA PSYCHOGENIC 7 0.0341
47 PANCREATIC INJURY 10 0.0328
48 PATIENT ISOLATION 7 0.0326
49 RESTLESS ARM SYNDROME 5 0.0321
50 BLADDER INJURY 10 0.0314
51 CYCLOTHYMIC DISORDER 5 0.0305
52 OVARIAN ADENOMA 5 0.0301
53 PSYCHOTIC SYMPTOM 61 0.0295
54 LEFT VENTRICULAR DILATATION 15 0.0294
55 MOROSE 5 0.0292
56 PLEUROTHOTONUS 26 0.0288
57 TRANSFERRIN SATURATION DECREASED 12 0.0281
58 PORTAL FIBROSIS 6 0.0280
59 SCHIZOPHRENIA 339 0.0279
60 SOCIAL ANXIETY DISORDER 18 0.0274
61 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 44 0.0260
62 SEXUALLY INAPPROPRIATE BEHAVIOUR 12 0.0258
63 HYPERPROLACTINAEMIA 167 0.0257
64 SCHIZOPHRENIA, PARANOID TYPE 9 0.0250
65 OROMANDIBULAR DYSTONIA 18 0.0247
66 GRANDIOSITY 9 0.0246
67 DELUSION OF GRANDEUR 11 0.0245
68 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 17 0.0242
69 HEPATOBILIARY DISEASE 15 0.0240
70 THYROXINE FREE DECREASED 13 0.0230
71 BLOOD BILIRUBIN DECREASED 14 0.0227
72 ASPARTATE AMINOTRANSFERASE DECREASED 12 0.0226
73 BLOOD GLUCOSE 4 0.0226
74 CEREBRAL ARTERY STENOSIS 11 0.0225
75 AKATHISIA 307 0.0225
76 OBSESSIVE-COMPULSIVE DISORDER 180 0.0224
77 TOXIC CARDIOMYOPATHY 5 0.0223
78 BLOOD FOLATE DECREASED 16 0.0220
79 BLOOD PROLACTIN INCREASED 103 0.0218
80 TESTICULAR ATROPHY 19 0.0218
81 HALLUCINATION, TACTILE 14 0.0210
82 DECREASED EYE CONTACT 6 0.0197
83 METABOLIC SYNDROME 32 0.0195
84 LABELLED DRUG-DRUG INTERACTION ISSUE 28 0.0193
85 EXCESSIVE MASTURBATION 4 0.0193
86 DELUSIONAL PERCEPTION 8 0.0193
87 CONGENITAL INGUINAL HERNIA 4 0.0191
88 NEUROLEPTIC MALIGNANT SYNDROME 227 0.0191
89 MYOCARDITIS 217 0.0189
90 PLEOCYTOSIS 11 0.0189
91 MEAN CELL VOLUME DECREASED 29 0.0188
92 PERSECUTORY DELUSION 46 0.0184
93 DYSLIPIDAEMIA 93 0.0183
94 EUPHORIC MOOD 187 0.0182
95 TROPONIN T INCREASED 23 0.0181
96 MEAN CELL HAEMOGLOBIN DECREASED 33 0.0180
97 CONVULSIVE THRESHOLD LOWERED 7 0.0178
98 RETROGRADE EJACULATION 14 0.0177
99 RETINAL DEPIGMENTATION 5 0.0163
100 OBSESSIVE-COMPULSIVE SYMPTOM 6 0.0163
101 COGWHEEL RIGIDITY 17 0.0162
102 HALLUCINATION, OLFACTORY 7 0.0161
103 ACCIDENTAL POISONING 22 0.0160
104 STENOSIS 30 0.0160
105 NEUTROPHIL COUNT INCREASED 163 0.0159
106 POOR PERSONAL HYGIENE 8 0.0155
107 SALIVARY HYPERSECRETION 151 0.0151
108 KETOSIS 16 0.0147
109 CSF PROTEIN INCREASED 12 0.0145
110 ECLAMPSIA 5 0.0136
111 POSTURING 7 0.0135
112 GALLBLADDER INJURY 26 0.0133
113 CONJUNCTIVAL DISORDER 5 0.0131
114 STEATOHEPATITIS 7 0.0131
115 MACROCYTOSIS 15 0.0129
116 SEDATION COMPLICATION 33 0.0129
117 HYPERLACTACIDAEMIA 34 0.0127
118 EXTRAPYRAMIDAL DISORDER 302 0.0121
119 AORTIC VALVE REPLACEMENT 15 0.0120
120 HYPOCHROMIC ANAEMIA 12 0.0118
121 HEPATITIS A 10 0.0118
122 MUTISM 17 0.0117
123 WRONG PATIENT RECEIVED PRODUCT 34 0.0116
124 HALLUCINATION, AUDITORY 183 0.0115
125 FOOD REFUSAL 10 0.0114
126 SUSPICIOUSNESS 8 0.0114
127 SITTING DISABILITY 7 0.0114
128 BORDERLINE PERSONALITY DISORDER 8 0.0113
129 HEMIANOPIA 11 0.0111
130 CATATONIA 58 0.0110
131 SEMEN VOLUME DECREASED 11 0.0110
132 SLEEP DEFICIT 23 0.0109
133 DELUSION 169 0.0109
134 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 18 0.0108
135 PSYCHOMOTOR RETARDATION 30 0.0107
136 ACUTE LEFT VENTRICULAR FAILURE 7 0.0104
137 RETROPERITONEAL FIBROSIS 6 0.0103
138 OCULOGYRIC CRISIS 22 0.0102
139 BINGE EATING 11 0.0102
140 DIARRHOEA INFECTIOUS 8 0.0102
141 COMPULSIVE SEXUAL BEHAVIOUR 8 0.0099
142 TROPONIN INCREASED 75 0.0098
143 UTERINE PAIN 10 0.0097
144 FOCAL DYSCOGNITIVE SEIZURES 11 0.0097
145 BLOOD UREA DECREASED 12 0.0097
146 PARKINSONISM 94 0.0096
147 LEFT ATRIAL DILATATION 12 0.0094
148 INCREASED APPETITE 179 0.0094
149 LEUKAEMIA 87 0.0092
150 MICROCYTIC ANAEMIA 19 0.0091
151 ANOSOGNOSIA 7 0.0091
152 HYPERLEUKOCYTOSIS 8 0.0090
153 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 5 0.0090
154 EJACULATION FAILURE 18 0.0090
155 ELECTROCARDIOGRAM T WAVE ABNORMAL 14 0.0090
156 PULMONARY VALVE INCOMPETENCE 13 0.0089
157 BANKRUPTCY 4 0.0089
158 AUTONOMIC NEUROPATHY 9 0.0089
159 STUPOR 28 0.0087
160 IMPAIRED SELF-CARE 18 0.0087
161 KIDNEY FIBROSIS 15 0.0086
162 RIGHT VENTRICULAR DILATATION 5 0.0086
163 HYPERTENSIVE HEART DISEASE 16 0.0085
164 SYSTOLIC DYSFUNCTION 9 0.0085
165 PENILE SIZE REDUCED 8 0.0084
166 ALCOHOL ABUSE 22 0.0082
167 SERUM FERRITIN DECREASED 14 0.0081
168 PSYCHOTIC DISORDER 237 0.0080
169 INTESTINAL PSEUDO-OBSTRUCTION 7 0.0080
170 NEGATIVISM 6 0.0079
171 UPPER AIRWAY OBSTRUCTION 7 0.0079
172 REDUCED FACIAL EXPRESSION 8 0.0079
173 ELECTROCARDIOGRAM QT PROLONGED 283 0.0079
174 PREMATURE EJACULATION 5 0.0078
175 INTESTINAL INFARCTION 7 0.0077
176 FLIGHT OF IDEAS 4 0.0077
177 DRUG SCREEN FALSE POSITIVE 21 0.0076
178 ABULIA 7 0.0076
179 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 5 0.0075
180 NEGATIVE THOUGHTS 22 0.0075
181 MENTAL IMPAIRMENT 182 0.0075
182 OBESITY 119 0.0075
183 OVERWEIGHT 40 0.0074
184 TONGUE BITING 15 0.0073
185 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 14 0.0071
186 AUDITORY DISORDER 10 0.0070
187 ANTICHOLINERGIC SYNDROME 11 0.0069
188 HYPERAMMONAEMIC ENCEPHALOPATHY 12 0.0069
189 SEDATION 180 0.0069
190 ACUTE PSYCHOSIS 17 0.0069
191 BREAST ABSCESS 7 0.0069
192 CHOLECYSTITIS INFECTIVE 19 0.0068
193 ARTERIOSCLEROSIS CORONARY ARTERY 45 0.0068
194 POSTICTAL STATE 7 0.0067
195 RED CELL DISTRIBUTION WIDTH INCREASED 28 0.0067
196 GALACTORRHOEA 42 0.0065
197 QRS AXIS ABNORMAL 5 0.0065
198 VICTIM OF CRIME 8 0.0065
199 POSTURE ABNORMAL 21 0.0064
200 ACUTE PULMONARY OEDEMA 36 0.0064
201 WHITE BLOOD CELL COUNT INCREASED 246 0.0064
202 DYSPHEMIA 28 0.0064
203 RESPIRATORY DEPRESSION 78 0.0064
204 HEPATITIS E 10 0.0063
205 LEUKOPENIA 316 0.0063
206 CHOLINERGIC SYNDROME 4 0.0063
207 LEFT VENTRICULAR DYSFUNCTION 42 0.0063
208 PSYCHOMOTOR SKILLS IMPAIRED 16 0.0061
209 PRIAPISM 21 0.0061
210 ANTISOCIAL BEHAVIOUR 6 0.0060
211 TESTICULAR PAIN 19 0.0060
212 DROWNING 6 0.0059
213 DYSTONIA 114 0.0059
214 LONG QT SYNDROME 14 0.0058
215 MONOCYTE COUNT INCREASED 21 0.0058
216 ATRIOVENTRICULAR BLOCK FIRST DEGREE 25 0.0058
217 CORONARY ARTERY STENOSIS 29 0.0058
218 HYPOMANIA 21 0.0057
219 SOPOR 75 0.0057
220 PSYCHIATRIC DECOMPENSATION 11 0.0056
221 ORCHITIS 6 0.0056
222 PRESCRIBED OVERDOSE 108 0.0056
223 VITAMIN B12 DECREASED 16 0.0055
224 BLOOD PHOSPHORUS INCREASED 15 0.0055
225 DRUG-DISEASE INTERACTION 4 0.0054
226 FOAMING AT MOUTH 11 0.0054
227 BLUNTED AFFECT 4 0.0054
228 CENTRAL OBESITY 4 0.0054
229 LOGORRHOEA 19 0.0054
230 CRYPTORCHISM 6 0.0053
231 FAECALOMA 29 0.0053
232 PULMONARY GRANULOMA 6 0.0053
233 ANION GAP INCREASED 7 0.0052
234 MYOGLOBIN BLOOD INCREASED 8 0.0052
235 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 4 0.0051
236 VOLVULUS 12 0.0051
237 MUSCLE RIGIDITY 60 0.0050
238 VENTRICULAR HYPOKINESIA 16 0.0050
239 HAEMANGIOMA OF LIVER 5 0.0050
240 DRUG LEVEL INCREASED 82 0.0049
241 NEUTROPHIL COUNT ABNORMAL 14 0.0049
242 SLOW SPEECH 12 0.0049
243 HYPOVENTILATION 16 0.0049
244 PITUITARY TUMOUR BENIGN 8 0.0049
245 DISORGANISED SPEECH 9 0.0049
246 CARDIOMYOPATHY 72 0.0049
247 SINUS TACHYCARDIA 69 0.0049
248 AKINESIA 10 0.0048
249 DEPRESSIVE SYMPTOM 17 0.0048
250 FLAT AFFECT 11 0.0047
251 PARANOIA 81 0.0047
252 LEFT VENTRICULAR HYPERTROPHY 20 0.0047
253 IRON DEFICIENCY 21 0.0047
254 SUICIDE ATTEMPT 282 0.0046
255 EXOPHTHALMOS 10 0.0046
256 INTENTIONAL SELF-INJURY 93 0.0046
257 BLOOD CREATINE PHOSPHOKINASE INCREASED 130 0.0045
258 HALLUCINATION, VISUAL 95 0.0045
259 LEUKOCYTOSIS 81 0.0045
260 FEAR OF DEATH 10 0.0044
261 IDIOPATHIC THROMBOCYTOPENIC PURPURA 7 0.0044
262 STRABISMUS 13 0.0044
263 SARCOMA 5 0.0044
264 NEUTROPHILIA 25 0.0044
265 RED BLOOD CELL COUNT INCREASED 12 0.0043
266 HEPATITIS ACUTE 28 0.0043
267 NEUTROPHIL COUNT DECREASED 175 0.0043
268 LYMPHOCYTE COUNT INCREASED 14 0.0043
269 VASOPLEGIA SYNDROME 7 0.0043
270 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 14 0.0042
271 LABILE BLOOD PRESSURE 5 0.0042
272 HIGH DENSITY LIPOPROTEIN DECREASED 14 0.0042
273 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 43 0.0042
274 HYPOREFLEXIA 8 0.0042
275 HEPATIC CYTOLYSIS 53 0.0042
276 REFLUX GASTRITIS 5 0.0042
277 CARDIAC DEATH 5 0.0041
278 GAMBLING DISORDER 11 0.0041
279 BEHAVIOUR DISORDER 22 0.0041
280 DROOLING 28 0.0040
281 APRAXIA 6 0.0040
282 HALLUCINATIONS, MIXED 17 0.0040
283 CLUMSINESS 11 0.0040
284 BLADDER DYSFUNCTION 4 0.0039
285 SUBILEUS 8 0.0038
286 ASPIRATION 42 0.0038
287 TORTICOLLIS 8 0.0038
288 INTRACRANIAL PRESSURE INCREASED 21 0.0038
289 SUBSTANCE USE DISORDER 12 0.0038
290 AUTONOMIC NERVOUS SYSTEM IMBALANCE 11 0.0038
291 HYPERACUSIS 14 0.0038
292 BLOOD BICARBONATE DECREASED 7 0.0037
293 THINKING ABNORMAL 68 0.0036
294 ILLUSION 6 0.0036
295 ELECTROCARDIOGRAM T WAVE INVERSION 8 0.0036
296 PLATELET COUNT INCREASED 47 0.0036
297 AORTIC DILATATION 4 0.0036
298 NECROSIS 20 0.0036
299 ECHOCARDIOGRAM ABNORMAL 5 0.0036
300 ELECTRIC SHOCK SENSATION 10 0.0036
301 ELECTROCARDIOGRAM ABNORMAL 28 0.0036
302 IMMUNE THROMBOCYTOPENIC PURPURA 10 0.0035
303 DRUG EFFECT VARIABLE 4 0.0035
304 SEXUAL DYSFUNCTION 41 0.0035
305 ELECTROENCEPHALOGRAM ABNORMAL 11 0.0035
306 MICTURITION DISORDER 12 0.0035
307 AGGRESSION 173 0.0035
308 COMA SCALE ABNORMAL 10 0.0034
309 EPIDIDYMITIS 4 0.0034
310 TREATMENT NONCOMPLIANCE 187 0.0034
311 HANGOVER 12 0.0034
312 APATHY 49 0.0034
313 CONGESTIVE CARDIOMYOPATHY 14 0.0034
314 PHYSICAL ASSAULT 7 0.0033
315 DRUG MONITORING PROCEDURE NOT PERFORMED 6 0.0033
316 OBSESSIVE THOUGHTS 6 0.0033
317 HYPERTHYROIDISM 48 0.0033
318 SELF INJURIOUS BEHAVIOUR 10 0.0033
319 DIASTOLIC DYSFUNCTION 10 0.0032
320 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 228 0.0032
321 VENTRICULAR HYPERTROPHY 8 0.0032
322 ASPHYXIA 26 0.0032
323 MANIA 52 0.0032
324 BRUXISM 17 0.0031
325 HOSTILITY 8 0.0031
326 SOCIAL PROBLEM 13 0.0031
327 DRUG ABUSE 261 0.0031
328 SOCIAL AVOIDANT BEHAVIOUR 18 0.0031
329 TYPE 2 DIABETES MELLITUS 104 0.0031
330 FEELINGS OF WORTHLESSNESS 4 0.0031
331 POISONING DELIBERATE 29 0.0031
332 DRUG LEVEL ABOVE THERAPEUTIC 14 0.0031
333 DRUG INTERACTION 483 0.0030
334 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 4 0.0030
335 FEELING GUILTY 4 0.0030
336 BLOOD CALCIUM ABNORMAL 5 0.0030
337 NEUTROPENIA 408 0.0030
338 TROPONIN I INCREASED 5 0.0030
339 LYMPHOCYTE COUNT DECREASED 53 0.0030
340 POTENTIATING DRUG INTERACTION 10 0.0030
341 MYDRIASIS 38 0.0030
342 HOMICIDAL IDEATION 12 0.0030
343 B-CELL LYMPHOMA 10 0.0029
344 PETIT MAL EPILEPSY 15 0.0029
345 BLOOD PH DECREASED 5 0.0029
346 BRADYPHRENIA 19 0.0029
347 BODY TEMPERATURE FLUCTUATION 6 0.0029
348 BLOOD CREATININE DECREASED 9 0.0029
349 EMOTIONAL POVERTY 5 0.0029
350 BUNDLE BRANCH BLOCK RIGHT 13 0.0028
351 CIRCULATORY COLLAPSE 48 0.0028
352 ORTHOSTATIC HYPOTENSION 49 0.0028
353 FOOD POISONING 15 0.0028
354 HEART VALVE INCOMPETENCE 8 0.0028
355 C-REACTIVE PROTEIN INCREASED 100 0.0027
356 AGRANULOCYTOSIS 51 0.0027
357 TETANY 5 0.0027
358 SUDDEN DEATH 29 0.0027
359 RHABDOMYOLYSIS 114 0.0027
360 SENSORY LOSS 22 0.0027
361 THROMBOCYTOSIS 10 0.0027
362 ENURESIS 11 0.0027
363 GENERALISED ANXIETY DISORDER 4 0.0027
364 BLEPHAROSPASM 17 0.0027
365 DEMYELINATION 11 0.0027
366 LIP DISORDER 5 0.0026
367 RESTLESSNESS 96 0.0026
368 TONGUE DISCOMFORT 11 0.0026
369 BRAIN DEATH 8 0.0026
370 ANORGASMIA 7 0.0026
371 AGITATION 189 0.0026
372 ALCOHOL INTERACTION 5 0.0026
373 POLYURIA 21 0.0026
374 HYPERTRIGLYCERIDAEMIA 15 0.0026
375 TACHYCARDIA 227 0.0026
376 TARDIVE DYSKINESIA 72 0.0025
377 POISONING 32 0.0025
378 MYOCLONUS 30 0.0025
379 SEROTONIN SYNDROME 48 0.0025
380 DIABETES INSIPIDUS 6 0.0025
381 STARING 6 0.0025
382 TOXICITY TO VARIOUS AGENTS 416 0.0025
383 VENTRICULAR ARRHYTHMIA 9 0.0025
384 PARADOXICAL DRUG REACTION 9 0.0024
385 SUPRAVENTRICULAR TACHYCARDIA 23 0.0024
386 EMPHYSEMA 24 0.0024
387 ERECTILE DYSFUNCTION 60 0.0023
388 LOSS OF LIBIDO 21 0.0023
389 EPILEPSY 71 0.0023
390 MITRAL VALVE INCOMPETENCE 26 0.0023
391 SUSPECTED COUNTERFEIT PRODUCT 9 0.0023
392 ILEUS PARALYTIC 10 0.0022
393 PSYCHOMOTOR HYPERACTIVITY 37 0.0022
394 WHITE BLOOD CELL COUNT DECREASED 241 0.0022
395 DRUG RESISTANCE 57 0.0022
396 HAEMATOCRIT DECREASED 44 0.0022
397 GASTROINTESTINAL HYPOMOTILITY 5 0.0022
398 SUICIDAL IDEATION 203 0.0022
399 HYPERNATRAEMIA 11 0.0022
400 BEDRIDDEN 29 0.0022
401 AMENORRHOEA 38 0.0022
402 NEUROLOGICAL DECOMPENSATION 5 0.0022
403 MENTAL DISORDER 94 0.0022
404 SELF-INJURIOUS IDEATION 9 0.0021
405 BREAST ENLARGEMENT 7 0.0021
406 IMPULSIVE BEHAVIOUR 8 0.0021
407 DISTURBANCE IN SOCIAL BEHAVIOUR 5 0.0021
408 PARTIAL SEIZURES 11 0.0021
409 HYPERTHERMIA 16 0.0021
410 METASTASES TO SPINE 7 0.0021
411 HYPOTHERMIA 21 0.0021
412 LEARNING DISORDER 5 0.0021
413 DIABETIC RETINOPATHY 7 0.0021
414 BRONCHOPNEUMONIA 7 0.0020
415 PNEUMONIA ASPIRATION 51 0.0020
416 COMA 97 0.0020
417 ALTERED STATE OF CONSCIOUSNESS 44 0.0020
418 HEPATITIS FULMINANT 6 0.0020
419 ABNORMAL BEHAVIOUR 80 0.0020
420 TRICUSPID VALVE INCOMPETENCE 16 0.0020
421 HYPOTONIA 20 0.0020
422 SYNOVITIS 36 0.0020
423 WEIGHT INCREASED 446 0.0020
424 PLATELET DISORDER 5 0.0020
425 BRAIN ABSCESS 5 0.0020
426 EATING DISORDER 42 0.0020
427 HYPERCHOLESTEROLAEMIA 19 0.0020
428 FIBROSIS 6 0.0019
429 MEAN CELL VOLUME INCREASED 5 0.0019
430 COMPULSIVE SHOPPING 4 0.0019
431 UMBILICAL HERNIA 9 0.0019
432 THERAPY PARTIAL RESPONDER 30 0.0019
433 ENCEPHALOPATHY 47 0.0019
434 TORSADE DE POINTES 15 0.0019
435 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
436 GAMMA-GLUTAMYLTRANSFERASE INCREASED 42 0.0019
437 PROTEIN TOTAL INCREASED 5 0.0019
438 FAECAL INCONTINENCE 9 0.0019
439 WHITE BLOOD CELL DISORDER 5 0.0019
440 ALCOHOL POISONING 5 0.0019
441 MOTOR DYSFUNCTION 19 0.0019
442 ENERGY INCREASED 11 0.0019
443 TENSION HEADACHE 8 0.0019
444 SUBSTANCE ABUSE 15 0.0018
445 COGNITIVE DISORDER 86 0.0018
446 HAEMODYNAMIC INSTABILITY 14 0.0018
447 URINARY INCONTINENCE 53 0.0018
448 AFFECTIVE DISORDER 14 0.0018
449 DRUG TOLERANCE DECREASED 5 0.0018
450 DYSPHORIA 9 0.0018
451 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 12 0.0018
452 ABNORMAL LOSS OF WEIGHT 12 0.0018
453 HYPERPHAGIA 7 0.0018
454 MIOSIS 14 0.0017
455 DEPRESSION SUICIDAL 6 0.0017
456 METABOLIC ACIDOSIS 55 0.0017
457 GASTROINTESTINAL NECROSIS 5 0.0017
458 VENTRICULAR FIBRILLATION 19 0.0017
459 MUSCLE CONTRACTIONS INVOLUNTARY 6 0.0017
460 LOWER RESPIRATORY TRACT INFECTION 77 0.0017
461 BLOOD ALKALINE PHOSPHATASE INCREASED 42 0.0017
462 ATAXIA 20 0.0017
463 EOSINOPHIL COUNT INCREASED 14 0.0017
464 HYPOGAMMAGLOBULINAEMIA 11 0.0017
465 DEPRESSED MOOD 87 0.0016
466 BLOOD PHOSPHORUS DECREASED 6 0.0016
467 DEPRESSED LEVEL OF CONSCIOUSNESS 64 0.0016
468 INCONTINENCE 17 0.0016
469 PROTEIN TOTAL DECREASED 6 0.0016
470 DISORIENTATION 63 0.0016
471 LIVER FUNCTION TEST ABNORMAL 46 0.0016
472 EXCORIATION 4 0.0016
473 GENERALISED TONIC-CLONIC SEIZURE 26 0.0016
474 SCREAMING 10 0.0016
475 BIPOLAR DISORDER 17 0.0016
476 DELIRIUM 54 0.0016
477 MULTIPLE DRUG OVERDOSE INTENTIONAL 5 0.0016
478 AORTIC ARTERIOSCLEROSIS 4 0.0016
479 HALLUCINATION 116 0.0015
480 HAEMOGLOBIN INCREASED 7 0.0015
481 CONFUSIONAL STATE 247 0.0015
482 BRADYKINESIA 9 0.0015
483 BLOOD LACTIC ACID INCREASED 8 0.0015
484 GRAND MAL CONVULSION 14 0.0015
485 HYPERGLYCAEMIA 55 0.0015
486 CEREBRAL ATROPHY 6 0.0015
487 HYPERSOMNIA 43 0.0015
488 IRRITABILITY 90 0.0015
489 INTENTIONAL OVERDOSE 96 0.0015
490 CHOLECYSTITIS CHRONIC 10 0.0015
491 LYMPHOMA 23 0.0015
492 CONTRAINDICATED PRODUCT ADMINISTERED 45 0.0015
493 CARDIO-RESPIRATORY ARREST 61 0.0015
494 CARDIOTOXICITY 13 0.0015
495 AFFECT LABILITY 14 0.0015
496 SINUS BRADYCARDIA 14 0.0014
497 SUICIDAL BEHAVIOUR 6 0.0014
498 DRUG USE DISORDER 12 0.0014
499 SLEEP APNOEA SYNDROME 27 0.0014
500 INFLAMMATORY MARKER INCREASED 7 0.0014
501 MULTIPLE DRUG OVERDOSE 7 0.0014
502 EJACULATION DISORDER 4 0.0014
503 MACULOPATHY 5 0.0014
504 FIBRIN D DIMER INCREASED 5 0.0014
505 VITAMIN D DECREASED 12 0.0014
506 HEPATIC STEATOSIS 26 0.0014
507 SPEECH DISORDER 73 0.0014
508 SOMNOLENCE 280 0.0014
509 ENTEROCOLITIS 8 0.0014
510 CHOKING 27 0.0014
511 HYPOKINESIA 20 0.0014
512 DRUG LEVEL DECREASED 14 0.0014
513 IMMOBILE 6 0.0014
514 ENDOCARDITIS 7 0.0014
515 WITHDRAWAL SYNDROME 57 0.0014
516 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
517 EJECTION FRACTION DECREASED 21 0.0013
518 CREPITATIONS 4 0.0013
519 RETINOPATHY 5 0.0013
520 HYPONATRAEMIA 75 0.0013
521 DYSKINESIA 54 0.0013
522 STATUS EPILEPTICUS 15 0.0013
523 DRUG TOXICITY 18 0.0013
524 EMBOLISM VENOUS 4 0.0013
525 UNRESPONSIVE TO STIMULI 34 0.0013
526 ACIDOSIS 10 0.0013
527 BLOOD TRIGLYCERIDES INCREASED 23 0.0013
528 IRON DEFICIENCY ANAEMIA 12 0.0013
529 SENSATION OF HEAVINESS 5 0.0013
530 SUSPECTED SUICIDE 6 0.0013
531 BODY TEMPERATURE INCREASED 26 0.0013
532 MYOPATHY 11 0.0013
533 LOSS OF CONSCIOUSNESS 162 0.0013
534 PULSE ABSENT 6 0.0013
535 BLOOD ALBUMIN DECREASED 10 0.0013
536 EOSINOPHILIA 22 0.0013
537 HAEMOGLOBIN DECREASED 128 0.0012
538 ALANINE AMINOTRANSFERASE INCREASED 76 0.0012
539 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
540 HYPERTONIA 7 0.0012
541 PSYCHIATRIC SYMPTOM 9 0.0012
542 PULMONARY CONGESTION 16 0.0012
543 FEELING DRUNK 9 0.0012
544 HYDRONEPHROSIS 9 0.0012
545 PANCREATITIS ACUTE 27 0.0012
546 DYSARTHRIA 45 0.0012
547 PAROSMIA 9 0.0012
548 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
549 DISTURBANCE IN ATTENTION 64 0.0012
550 COLITIS ISCHAEMIC 8 0.0012
551 TRANSAMINASES INCREASED 26 0.0012
552 ARTERIOSCLEROSIS 11 0.0012
553 AMNESIA 76 0.0012
554 ALCOHOLISM 5 0.0012
555 GASTROENTERITIS 17 0.0012
556 REBOUND EFFECT 13 0.0011
557 TENSION 7 0.0011
558 HEPATOCELLULAR INJURY 16 0.0011
559 VITAMIN D DEFICIENCY 11 0.0011
560 PANIC ATTACK 41 0.0011
561 BLOOD DISORDER 9 0.0011
562 JAUNDICE 30 0.0011
563 SPLENOMEGALY 13 0.0011
564 PRODUCT PRESCRIBING ISSUE 24 0.0011
565 RESTLESS LEGS SYNDROME 20 0.0011
566 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
567 GYNAECOMASTIA 34 0.0011
568 ARRHYTHMIA 52 0.0011
569 ABDOMINAL HERNIA 5 0.0011
570 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 57 0.0011
571 THERAPY NON-RESPONDER 49 0.0011
572 INTESTINAL ISCHAEMIA 6 0.0011
573 CHOKING SENSATION 6 0.0011
574 HYPERLIPIDAEMIA 13 0.0011
575 FEAR 29 0.0011
576 INITIAL INSOMNIA 11 0.0011
577 NEPHROPATHY TOXIC 12 0.0011
578 THIRST 19 0.0011
579 SKIN ABRASION 5 0.0011
580 MYOCARDIAL ISCHAEMIA 12 0.0011
581 OVERDOSE 227 0.0011
582 RED BLOOD CELL COUNT DECREASED 30 0.0010
583 CARDIOGENIC SHOCK 15 0.0010
584 DISSOCIATION 8 0.0010
585 PERICARDIAL EFFUSION 24 0.0010
586 GENERAL PHYSICAL CONDITION ABNORMAL 7 0.0010
587 STRESS CARDIOMYOPATHY 6 0.0010
588 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
589 EYE MOVEMENT DISORDER 7 0.0010
590 HEAD INJURY 32 0.0010
591 PLEURISY 6 0.0010
592 ABDOMINAL TENDERNESS 5 0.0010
593 HEMIPARESIS 17 0.0010
594 HEPATITIS C 12 0.0010
595 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
596 VENTRICULAR EXTRASYSTOLES 10 0.0010
597 EPSTEIN-BARR VIRUS INFECTION 6 0.0010
598 BUNDLE BRANCH BLOCK LEFT 4 0.0009
599 NYSTAGMUS 5 0.0009
600 VERTIGO 57 0.0009
601 POOR QUALITY SLEEP 20 0.0009
602 HIATUS HERNIA 12 0.0009
603 CONSTIPATION 201 0.0009
604 CARDIAC ARREST 76 0.0009
605 RESPIRATORY FAILURE 67 0.0009
606 TREMOR 152 0.0009
607 SHOCK 21 0.0009
608 PLATELET COUNT DECREASED 97 0.0009
609 AUTISM SPECTRUM DISORDER 5 0.0009
610 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
611 BRAIN INJURY 9 0.0009
612 CARDIOMEGALY 11 0.0009
613 HYPOTENSION 179 0.0009
614 ABNORMAL WEIGHT GAIN 11 0.0009
615 CHOLESTASIS 17 0.0009
616 PREMATURE LABOUR 5 0.0009
617 PRODUCT USE IN UNAPPROVED INDICATION 219 0.0009
618 SLEEP DISORDER 62 0.0009
619 HYPERTENSION 186 0.0009
620 INTESTINAL OBSTRUCTION 33 0.0009
621 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
622 TREATMENT FAILURE 72 0.0009
623 EXERCISE TOLERANCE DECREASED 5 0.0009
624 INTENTIONAL PRODUCT MISUSE 76 0.0009
625 ENCEPHALITIS 6 0.0009
626 CONJUNCTIVITIS 16 0.0009
627 JOINT DISLOCATION 9 0.0009
628 SYMPTOM RECURRENCE 5 0.0008
629 TONGUE DISORDER 6 0.0008
630 CARDIOVASCULAR DISORDER 21 0.0008
631 MUSCLE TWITCHING 19 0.0008
632 FOETAL GROWTH RESTRICTION 5 0.0008
633 MAJOR DEPRESSION 6 0.0008
634 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
635 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21 0.0008
636 LIVER INJURY 20 0.0008
637 SKIN ULCER 21 0.0008
638 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
639 SEIZURE 93 0.0008
640 PULMONARY OEDEMA 36 0.0008
641 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
642 FLUID INTAKE REDUCED 4 0.0008
643 BLOOD CHOLESTEROL INCREASED 37 0.0008
644 SLUGGISHNESS 8 0.0008
645 AMMONIA INCREASED 4 0.0008
646 LETHARGY 45 0.0008
647 DIFFUSE LARGE B-CELL LYMPHOMA 6 0.0008
648 HEPATIC ENZYME INCREASED 53 0.0008
649 GASTROINTESTINAL CARCINOMA 7 0.0008
650 PELVIC PAIN 14 0.0008
651 CHOLELITHIASIS 25 0.0008
652 DYSGRAPHIA 5 0.0008
653 THERAPEUTIC RESPONSE DECREASED 46 0.0008
654 INFLAMMATION 39 0.0008
655 MEDICATION ERROR 42 0.0008
656 BREAST PAIN 8 0.0007
657 DIARRHOEA HAEMORRHAGIC 7 0.0007
658 HEPATIC CIRRHOSIS 14 0.0007
659 WRONG PRODUCT ADMINISTERED 5 0.0007
660 HYPOCALCAEMIA 14 0.0007
661 INFARCTION 5 0.0007
662 HEPATIC FAILURE 22 0.0007
663 VENTRICULAR TACHYCARDIA 12 0.0007
664 THROMBOCYTOPENIA 81 0.0007
665 BLOOD UREA INCREASED 12 0.0007
666 CONDITION AGGRAVATED 217 0.0007
667 HYPERHIDROSIS 91 0.0007
668 OVARIAN CYST 7 0.0007
669 ANGINA PECTORIS 20 0.0007
670 ASPARTATE AMINOTRANSFERASE INCREASED 37 0.0007
671 BLOOD URIC ACID INCREASED 4 0.0007
672 VISUAL FIELD DEFECT 5 0.0007
673 BLOOD SODIUM DECREASED 13 0.0007
674 GASTRITIS 18 0.0007
675 LACTIC ACIDOSIS 22 0.0007
676 DEEP VEIN THROMBOSIS 44 0.0007
677 CARDIAC DISORDER 63 0.0007
678 HYPOKALAEMIA 31 0.0007
679 DRUG INEFFECTIVE 872 0.0007
680 PALLOR 18 0.0007
681 CORONARY ARTERY DISEASE 20 0.0007
682 HYPOTHYROIDISM 21 0.0007
683 INSOMNIA 171 0.0006
684 HYPOGLYCAEMIA 31 0.0006
685 LOW BIRTH WEIGHT BABY 5 0.0006
686 HEPATITIS 16 0.0006
687 ACUTE RESPIRATORY FAILURE 12 0.0006
688 MYASTHENIA GRAVIS 5 0.0006
689 DIZZINESS POSTURAL 6 0.0006
690 PULMONARY EMBOLISM 58 0.0006
691 DISABILITY 12 0.0006
692 DRUG-INDUCED LIVER INJURY 19 0.0006
693 ANXIETY 172 0.0006
694 DIABETES MELLITUS 46 0.0006
695 CARDIAC FAILURE 48 0.0006
696 ACUTE HEPATIC FAILURE 8 0.0006
697 SKIN HYPERPIGMENTATION 5 0.0006
698 DRUG WITHDRAWAL SYNDROME 51 0.0006
699 HYPOACUSIS 25 0.0006
700 NOCTURIA 7 0.0006
701 RESPIRATORY TRACT INFECTION 15 0.0006
702 CYTOPENIA 7 0.0006
703 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
704 BLOOD PRESSURE DECREASED 37 0.0006
705 BALANCE DISORDER 48 0.0006
706 BLOOD BILIRUBIN INCREASED 15 0.0006
707 MALAISE 243 0.0006
708 MENSTRUATION DELAYED 6 0.0006
709 ANOSMIA 8 0.0006
710 EMOTIONAL DISORDER 17 0.0006
711 OESOPHAGITIS 6 0.0005
712 HYPOPHAGIA 14 0.0005
713 INFUSION SITE PAIN 7 0.0005
714 CONVULSION 31 0.0005
715 DIABETIC KETOACIDOSIS 13 0.0005
716 CHEST PAIN 100 0.0005
717 ACUTE KIDNEY INJURY 82 0.0005
718 PERICARDITIS 9 0.0005
719 SKIN INFECTION 6 0.0005
720 FACE OEDEMA 9 0.0005
721 BLOOD CALCIUM DECREASED 6 0.0005
722 FALL 176 0.0005
723 DRUG INTOLERANCE 51 0.0005
724 DISEASE RECURRENCE 25 0.0005
725 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
726 CRYING 19 0.0005
727 QUALITY OF LIFE DECREASED 7 0.0005
728 RENAL FAILURE ACUTE 22 0.0005
729 ATELECTASIS 5 0.0005
730 ATRIOVENTRICULAR BLOCK 4 0.0005
731 TENDONITIS 8 0.0005
732 APHTHOUS ULCER 4 0.0005
733 CAESAREAN SECTION 6 0.0005
734 TACHYPNOEA 7 0.0005
735 MUSCULOSKELETAL STIFFNESS 45 0.0005
736 HAEMATEMESIS 13 0.0005
737 INFLUENZA 57 0.0005
738 SEPSIS 57 0.0005
739 HEAD DISCOMFORT 9 0.0005
740 PRODUCT PRESCRIBING ERROR 12 0.0005
741 HYPOMAGNESAEMIA 7 0.0005
742 HOSPITALISATION 77 0.0005
743 BLOOD TEST ABNORMAL 7 0.0005
744 DEPRESSION 113 0.0005
745 HEART RATE INCREASED 49 0.0005
746 MUSCLE TIGHTNESS 8 0.0005
747 ATRIAL FIBRILLATION 48 0.0005
748 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
749 SMALL INTESTINAL OBSTRUCTION 6 0.0005
750 TEMPERATURE INTOLERANCE 5 0.0005
751 URINARY RETENTION 16 0.0005
752 ATRIAL SEPTAL DEFECT 4 0.0005
753 TRANSIENT ISCHAEMIC ATTACK 16 0.0005
754 FULL BLOOD COUNT ABNORMAL 5 0.0005
755 GENERAL PHYSICAL HEALTH DETERIORATION 54 0.0005
756 PANCYTOPENIA 26 0.0005
757 MULTI-ORGAN FAILURE 8 0.0005
758 NIGHTMARE 16 0.0005
759 DIPLOPIA 12 0.0005
760 DRY EYE 23 0.0005
761 BLOOD PRESSURE FLUCTUATION 11 0.0005
762 VIRAL INFECTION 15 0.0005
763 THERAPY CESSATION 23 0.0004
764 MALNUTRITION 5 0.0004
765 RESPIRATORY TRACT CONGESTION 7 0.0004
766 LUNG NEOPLASM MALIGNANT 18 0.0004
767 MOVEMENT DISORDER 14 0.0004
768 VISUAL IMPAIRMENT 54 0.0004
769 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
770 ABNORMAL DREAMS 12 0.0004
771 ADVERSE DRUG REACTION 39 0.0004
772 PULMONARY HYPERTENSION 9 0.0004
773 ORAL DISCOMFORT 6 0.0004
774 APHONIA 6 0.0004
775 HYPOXIA 15 0.0004
776 OROPHARYNGEAL PAIN 39 0.0004
777 COMPLETED SUICIDE 35 0.0004
778 ANHEDONIA 11 0.0004
779 DRUG EFFECT INCOMPLETE 15 0.0004
780 EAR PAIN 8 0.0004
781 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
782 DYSURIA 15 0.0004
783 PYREXIA 141 0.0004
784 MYOCARDIAL INFARCTION 71 0.0004
785 AGEUSIA 10 0.0004
786 MEMORY IMPAIRMENT 55 0.0004
787 SYNCOPE 40 0.0004
788 EMOTIONAL DISTRESS 48 0.0004
789 ABDOMINAL PAIN 92 0.0004
790 DRUG DISPENSING ERROR 6 0.0004
791 VOMITING 183 0.0004
792 LIMB DISCOMFORT 12 0.0004
793 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 13 0.0004
794 NERVOUS SYSTEM DISORDER 12 0.0004
795 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
796 OFF LABEL USE 333 0.0004
797 PANCREATITIS 20 0.0004
798 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
799 ACUTE MYOCARDIAL INFARCTION 11 0.0004
800 BLOOD POTASSIUM INCREASED 6 0.0004
801 BLOOD CREATININE INCREASED 24 0.0004
802 MOOD ALTERED 10 0.0004
803 MULTIPLE FRACTURES 6 0.0004
804 APHASIA 11 0.0004
805 ABDOMINAL DISTENSION 38 0.0004
806 ANAEMIA 69 0.0004
807 DRUG ADMINISTRATION ERROR 11 0.0004
808 LYMPHOPENIA 5 0.0004
809 COVID-19 62 0.0004
810 PNEUMONIA 113 0.0003
811 MOBILITY DECREASED 25 0.0003
812 FEEDING DISORDER 7 0.0003
813 PLEURAL EFFUSION 21 0.0003
814 OEDEMA PERIPHERAL 42 0.0003
815 WEIGHT DECREASED 96 0.0003
816 DYSSTASIA 10 0.0003
817 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
818 BRADYCARDIA 18 0.0003
819 DIZZINESS 169 0.0003
820 DRUG WITHDRAWAL SYNDROME NEONATAL 5 0.0003
821 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
822 DRUG DEPENDENCE 53 0.0003
823 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
824 DEMENTIA 9 0.0003
825 VISION BLURRED 44 0.0003
826 SWOLLEN TONGUE 10 0.0003
827 CYANOSIS 5 0.0003
828 BRAIN OEDEMA 4 0.0003
829 ALOPECIA 62 0.0003
830 FEELING JITTERY 6 0.0003
831 HEPATOTOXICITY 7 0.0003
832 ABSCESS 5 0.0003
833 INFECTION 45 0.0003
834 URINARY TRACT INFECTION 53 0.0003
835 DECREASED APPETITE 72 0.0003
836 FEELING HOT 19 0.0003
837 RENAL IMPAIRMENT 26 0.0003
838 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
839 JOINT STIFFNESS 8 0.0003
840 RESPIRATORY DISORDER 9 0.0003
841 HEPATIC FUNCTION ABNORMAL 11 0.0003
842 RESPIRATORY ARREST 8 0.0003
843 EXPOSURE DURING PREGNANCY 18 0.0003
844 BLOOD PRESSURE INCREASED 44 0.0003
845 DYSPHAGIA 27 0.0003
846 THERAPY INTERRUPTED 20 0.0003
847 NIGHT SWEATS 9 0.0003
848 DEHYDRATION 37 0.0003
849 OEDEMA 15 0.0003
850 SEPTIC SHOCK 12 0.0003
851 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
852 ACCIDENTAL OVERDOSE 10 0.0003
853 PALPITATIONS 32 0.0003
854 MELAENA 6 0.0003
855 GAIT DISTURBANCE 52 0.0003
856 FATIGUE 210 0.0003
857 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
858 BLOOD GLUCOSE INCREASED 50 0.0003
859 PROTEINURIA 5 0.0003
860 TINNITUS 12 0.0003
861 EYE IRRITATION 15 0.0003
862 ANKLE FRACTURE 4 0.0003
863 HAEMORRHOIDS 5 0.0003
864 MUSCULAR WEAKNESS 29 0.0003
865 INFLUENZA LIKE ILLNESS 21 0.0003
866 MENTAL STATUS CHANGES 7 0.0003
867 OXYGEN SATURATION DECREASED 14 0.0002
868 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
869 DRY MOUTH 20 0.0002
870 TASTE DISORDER 5 0.0002
871 FOETAL EXPOSURE DURING PREGNANCY 20 0.0002
872 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
873 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
874 ASCITES 7 0.0002
875 SKIN BURNING SENSATION 17 0.0002
876 DYSPNOEA 134 0.0002
877 GASTROINTESTINAL DISORDER 21 0.0002
878 LIVER FUNCTION TEST INCREASED 5 0.0002
879 PREMATURE BABY 7 0.0002
880 HYPOAESTHESIA 34 0.0002
881 ASTHENIA 85 0.0002
882 RENAL FAILURE 30 0.0002
883 EAR INFECTION 6 0.0002
884 FEELING ABNORMAL 54 0.0002
885 RASH MACULO-PAPULAR 5 0.0002
886 CEREBRAL HAEMORRHAGE 8 0.0002
887 PSORIASIS 29 0.0002
888 HAEMOPTYSIS 6 0.0002
889 EYE SWELLING 8 0.0002
890 WOUND 6 0.0002
891 CEREBROVASCULAR ACCIDENT 36 0.0002
892 DYSPNOEA EXERTIONAL 8 0.0002
893 OCULAR HYPERAEMIA 10 0.0002
894 GASTRIC ULCER 4 0.0002
895 ECZEMA 11 0.0002
896 INTERSTITIAL LUNG DISEASE 10 0.0002
897 NEURALGIA 5 0.0002
898 CHILLS 24 0.0002
899 DRUG EFFECT DECREASED 11 0.0002
900 LUNG DISORDER 10 0.0002
901 DYSPEPSIA 20 0.0002
902 RASH PRURITIC 11 0.0002
903 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
904 DEATH 174 0.0002
905 SWELLING FACE 13 0.0002
906 BLOOD POTASSIUM DECREASED 6 0.0002
907 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
908 CHEST DISCOMFORT 20 0.0002
909 RASH GENERALISED 5 0.0002
910 COLITIS 7 0.0002
911 VISUAL ACUITY REDUCED 6 0.0002
912 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
913 HEADACHE 111 0.0002
914 MYALGIA 30 0.0002
915 EPISTAXIS 13 0.0002
916 NAUSEA 134 0.0002
917 POLLAKIURIA 7 0.0002
918 CELLULITIS 8 0.0002
919 FLATULENCE 9 0.0002
920 ACNE 12 0.0002
921 LIVER DISORDER 7 0.0002
922 MOOD SWINGS 5 0.0002
923 ADVERSE EVENT 14 0.0002
924 STAPHYLOCOCCAL INFECTION 5 0.0002
925 ABDOMINAL PAIN UPPER 31 0.0002
926 DIARRHOEA 96 0.0001
927 ANGER 5 0.0001
928 ROAD TRAFFIC ACCIDENT 6 0.0001
929 PRODUCT USE ISSUE 26 0.0001
930 RASH 60 0.0001
931 NERVOUSNESS 7 0.0001
932 MUSCULOSKELETAL PAIN 7 0.0001
933 ABDOMINAL DISCOMFORT 22 0.0001
934 SKIN EXFOLIATION 11 0.0001
935 ILLNESS 13 0.0001
936 COUGH 34 0.0001
937 FEBRILE NEUTROPENIA 8 0.0001
938 CHRONIC KIDNEY DISEASE 9 0.0001
939 HAEMORRHAGE 12 0.0001
940 INCORRECT DOSE ADMINISTERED 26 0.0001
941 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
942 SKIN IRRITATION 5 0.0001
943 MUSCLE SPASMS 20 0.0001
944 BRONCHITIS 8 0.0001
945 NECK PAIN 6 0.0001
946 BREAST CANCER 10 0.0001
947 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
948 PRODUCTIVE COUGH 5 0.0001
949 THROMBOSIS 8 0.0001
950 EXTRA DOSE ADMINISTERED 4 0.0001
951 BLINDNESS 4 0.0001
952 MIGRAINE 9 0.0001
953 HOT FLUSH 7 0.0001
954 RHINORRHOEA 6 0.0001
955 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
956 PAIN 56 0.0001
957 HAEMATOCHEZIA 5 0.0001
958 NEOPLASM MALIGNANT 6 0.0001
959 PARAESTHESIA 14 0.0001
960 EYE PAIN 5 0.0001
961 HERPES ZOSTER 5 0.0001
962 NASOPHARYNGITIS 16 0.0001
963 BURNING SENSATION 6 0.0001
964 PERIPHERAL SWELLING 13 0.0001
965 WHEEZING 5 0.0001
966 PRODUCT DOSE OMISSION 5 0.0001
967 DISEASE PROGRESSION 9 0.0001
968 CARDIAC FAILURE CONGESTIVE 6 0.0001
969 BACK PAIN 17 0.0001
970 DEPENDENCE 4 0.0001
971 ANAPHYLACTIC REACTION 4 0.0001
972 PRODUCT DOSE OMISSION ISSUE 21 0.0001
973 INJURY 5 0.0001
974 ASTHMA 8 0.0001
975 FLUSHING 7 0.0001
976 UNDERDOSE 5 0.0001
977 DYSPHONIA 4 0.0001
978 DYSGEUSIA 5 0.0001
979 DISCOMFORT 4 0.0001
980 ARTHRITIS 5 0.0001
981 PRURITUS 23 0.0001
982 JOINT SWELLING 7 0.0001
983 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
984 DRUG DOSE OMISSION 9 0.0001
985 HYPERSENSITIVITY 10 0.0001
986 ARTHRALGIA 21 0.0001
987 URTICARIA 7 0.0000
988 CONTUSION 4 0.0000
989 PAIN IN EXTREMITY 12 0.0000
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
991 INJECTION SITE PAIN 10 0.0000
992 ERYTHEMA 6 0.0000